AKER BIOMARINE ASA (AKBM.OL) Stock Price & Overview

OSL:AKBM • NO0010886625

104 NOK
-2.4 (-2.26%)
Last: Mar 6, 2026, 07:00 PM

The current stock price of AKBM.OL is 104 NOK. Today AKBM.OL is down by -2.26%. In the past month the price increased by 11.83%. In the past year, price increased by 61.49%.

AKBM.OL Key Statistics

52-Week Range43.65 - 110
Current AKBM.OL stock price positioned within its 52-week range.
1-Month Range92 - 110
Current AKBM.OL stock price positioned within its 1-month range.
Market Cap
9.121B
P/E
N/A
Fwd P/E
44.63
EPS (TTM)
-3.60
Dividend Yield
N/A

AKBM.OL Stock Performance

Today
-2.26%
1 Week
+3.79%
1 Month
+11.83%
3 Months
+12.92%
Longer-term
6 Months +15.68%
1 Year +61.49%
2 Years +62.50%
3 Years +167.70%
5 Years N/A
10 Years N/A

AKBM.OL Stock Chart

AKER BIOMARINE ASA / AKBM Daily stock chart

AKBM.OL Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to AKBM.OL. When comparing the yearly performance of all stocks, AKBM.OL is one of the better performing stocks in the market, outperforming 88.25% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
AKBM.OL Full Technical Analysis Report

AKBM.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AKBM.OL. AKBM.OL has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
AKBM.OL Full Fundamental Analysis Report

AKBM.OL Earnings

Next Earnings DateApr 30, 2026
Last Earnings DateFeb 12, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise -10.80%
AKBM.OL Earnings History

AKBM.OL Forecast & Estimates

9 analysts have analysed AKBM.OL and the average price target is 96.9 NOK. This implies a price decrease of -6.83% is expected in the next year compared to the current price of 104.

For the next year, analysts expect an EPS growth of 70% and a revenue growth -15.72% for AKBM.OL


Analysts
Analysts77.78
Price Target96.9 (-6.83%)
EPS Next Y70%
Revenue Next Year-15.72%
AKBM.OL Forecast & Estimates

AKBM.OL Groups

Sector & Classification

Index Membership

AKBM.OL Financial Highlights

Over the last trailing twelve months AKBM.OL reported a non-GAAP Earnings per Share(EPS) of -3.6. The EPS decreased by -115.95% compared to the year before.


Income Statements
Revenue(TTM)265.70M
Net Income(TTM)-34.10M
Industry RankSector Rank
PM (TTM) N/A
ROA -8.56%
ROE -22.75%
Debt/Equity 1.07
Chartmill High Growth Momentum
EPS Q2Q%-100%
Sales Q2Q%15.21%
EPS 1Y (TTM)-115.95%
Revenue 1Y (TTM)2.31%
AKBM.OL financials

AKBM.OL Ownership

Ownership
Inst Owners6.04%
Shares87.70M
Float9.35M
Ins Owners6.14%
Short Float %N/A
Short RatioN/A
AKBM.OL Ownership

AKBM.OL Competitors/Peers

The largest stocks on the EU markets in the "Packaged Foods & Meats" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
BN DANONE16.8447.725B
BSN DANONE16.8347.711B
JDEP JDE PEET'S NV16.7415.475B
JDE JDE PEET'S NV16.7715.456B
KRZ KERRY GROUP PLC-A13.2411.229B
LOTB LOTUS BAKERIES44.728.397B
MICC MAGNUM ICE CREAM CO NV/THE12.388.003B
GL9 GLANBIA PLC13.974.149B
LOUP L.D.C. SA11.193.523B
SZU SUEDZUCKER AG29.472.039B
NWL NEWPRINCES SPA10.65877.921M
SAVE SAVENCIA SA7.02827.77M
BON BONDUELLE SCA6.33278.986M

About AKBM.OL

Company Profile

AKBM logo image Aker BioMarine AS is a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.

Company Info

AKER BIOMARINE ASA

Oksenoyveien 10, P.O. Box 496

Lysaker AKERSHUS NO

Employees: 249

AKBM Company Website

AKBM Investor Relations

Phone: 4724130000

AKER BIOMARINE ASA / AKBM.OL FAQ

Can you describe the business of AKER BIOMARINE ASA?

Aker BioMarine AS is a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.


Can you provide the latest stock price for AKER BIOMARINE ASA?

The current stock price of AKBM.OL is 104 NOK. The price decreased by -2.26% in the last trading session.


What is the dividend status of AKER BIOMARINE ASA?

AKBM.OL does not pay a dividend.


What is the ChartMill technical and fundamental rating of AKBM stock?

AKBM.OL has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Would investing in AKER BIOMARINE ASA be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AKBM.OL.


What is AKER BIOMARINE ASA worth?

AKER BIOMARINE ASA (AKBM.OL) has a market capitalization of 9.12B NOK. This makes AKBM.OL a Mid Cap stock.


Can you provide the ownership details for AKBM stock?

You can find the ownership structure of AKER BIOMARINE ASA (AKBM.OL) on the Ownership tab.